Analisis Kinerja Keuangan PT. Kalbe Farma Tbk, Sebelum dan Sesudah Akuisisi

SILVIA MEGA SARI

Abstract


Abstract: This study aims to identify and analyze the company'sfinancial performance before and after the acquisition of PT KalbeFarma Tbk. The population of this research is all the pharmaceuticalcompanies that are going public in Indonesia. The sample was PT.Kalbe Farma Tbk (KLBF) which is one of the pharmaceuticalcompanies that have been acquired in 2005. Processing and analysisof data using measurement tools EVA (Economic Value Added) withthe help of Microsoft Excel 2007. From the analysis by using ameasuring instrument Economic Value Added (EVA) can be seen thatthe value of Economic Value Added (EVA) PT Kalbe Farma Tbk from2001 to 2010 increased. The average value of EVA prior to theacquisition in the amount of 191,513 and the average EVA value afterthe acquisition is equal to 815,621. Keywords: financial performance, acquisition, economic value added (EVA), business combinations, investment.


Full Text: PDF

Refbacks

  • There are currently no refbacks.